Shares of Large-cap consumer staples company CVS Health moved -0.0 this evening, and are now trading at $78.94 per share. On the other hand, the average analyst target price for the stock is $87.39.
CVS Health Corporation provides health services in the United States.
CVS Health Investors Should Consider This:
-
CVS Health has moved -15.3% over the last year.
-
The company has a price to earnings growth (PEG) ratio of 3.93. A number between 0 and 1 could mean that the market is undervaluing CVS Health's estimated growth potential
-
Its Price to Book (P/B) ratio is 1.37
-
CVS Health currently returns an annual dividend yield of 3.0%.
Understanding CVS Health's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 347,809,000 | 333,780,000 | 4 | 100.0 |
| 2022 | 322,467,000 | 314,513,000 | 2 | -60.0 |
| 2021 | 292,111,000 | 278,801,000 | 5 | 0.0 |
| 2020 | 268,706,000 | 254,795,000 | 5 | 0.0 |
| 2019 | 256,776,000 | 244,789,000 | 5 | 150.0 |
| 2018 | 194,579,000 | 190,558,000 | 2 |
Over the last 6 years, CVS Health's operating margins have averaged 3.8%, which is similar to the 4.35% Pharmaceutical Retail industry average. We also note that the company's operating margins have a high coefficient of variability at 2216.62%. On the other hand, we note that the firm's margins are growing at a 12.4% compounded average yearly rate.
